Clinical Trials on Metabolism and Clearance of Cyanidin 3 Glucoside in Australia
Total 621 results
-
University of AdelaideCompletedIndividuals at Risk of Developing DiabetesAustralia
-
Allievex CorporationCompletedMucopolysaccharidosis Type IIIB | Mucopolysaccharidosis Type 3 B | MPS III B | MPS 3 BUnited States, Spain, Turkey, Taiwan, Australia, Colombia, Germany, United Kingdom
-
University of AdelaideCompletedInsulin ResistanceAustralia
-
University of AdelaideRoyal Adelaide Hospital; University of South AustraliaTerminatedInsulin ResistanceAustralia
-
AstraZenecaCompletedMetabolic Syndrome | DyslipidemiaAustralia
-
The University of Western AustraliaNational Heart Foundation, AustraliaCompletedObesity | Cardiovascular Disease | Lipid DisordersAustralia
-
University of AdelaideCompletedDiabetes | Metabolic SyndromeAustralia
-
The University of Western AustraliaCompletedObesity | Insulin Resistance | DyslipidemiaAustralia
-
AstraZenecaCompletedMetabolic Syndrome | DyslipidemiaAustralia
-
University of AdelaideCompletedInsulin Resistance | Type 2 DiabetesAustralia
-
The University of Western AustraliaCompletedObesity | Insulin Resistance | DyslipidemiaAustralia
-
The University of Western AustraliaUnknown
-
Menzies Institute for Medical ResearchDeakin UniversityActive, not recruiting
-
University of AdelaideCompletedObesity | Type 2 DiabetesAustralia
-
University of AdelaideCompletedObesity | Type 2 DiabetesAustralia
-
Garvan Institute of Medical ResearchCompleted
-
Gold Coast Hospital and Health ServiceUniversity of CanberraCompletedType 1 Diabetes MellitusAustralia
-
University of AdelaideSalk Institute for Biological StudiesTerminatedInsulin Resistance | Type2 DiabetesAustralia
-
Zosano Pharma CorporationCompleted
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesGermany, Australia
-
Baker Heart Research InstituteNational Heart Foundation, AustraliaUnknownMetabolic SyndromeAustralia
-
University of AdelaideAustralasian Hyperbaric & Diving Medicine Research TrustCompletedOverweight and Obesity | Insulin SensitivityAustralia
-
Monash UniversityNational Heart Foundation, AustraliaWithdrawn
-
Medical University of GrazCompleted
-
Western Sydney Local Health DistrictCompletedMetabolic Syndrome | HypercholesterolemiaAustralia
-
Marcus SaemannCompleted
-
NGM Biopharmaceuticals, IncNGM Biopharmaceuticals Australia Pty LtdCompleted
-
Royal Perth HospitalRecruitingObesity | Type 2 Diabetes Mellitus | Metabolic SyndromeAustralia
-
Olive Lifesciences Pvt LtdCollege of Health and Biomedicine, Victoria UniversityUnknownObesity | Metabolic SyndromeAustralia
-
Baker Heart Research InstituteUnknownObesity | Metabolic Syndrome | Insulin ResistanceAustralia
-
The University of Western AustraliaKing Edward Memorial HospitalCompletedGestational Diabetes MellitusAustralia
-
SanofiTerminatedDiabetes Mellitus, Type 2Australia
-
Baker Heart Research InstituteNational Health and Medical Research Council, Australia; Hoffmann-La Roche; Diabetes...CompletedDiabetes Mellitus, Type 2Australia
-
Medical University of ViennaMedtronicUnknownHypoglycemia | Roux-en-y Gastric Bypass | Continuous Glucose MonitoringAustria
-
Medical University of ViennaCompleted
-
Glycomine, Inc.Recruiting24-Week Study to Assess the PD, Safety, Tolerability, and PK of GLM101 in Participants With PMM2-CDGPmm2-CDGSpain, Australia, United States
-
University of AdelaideSalk Institute for Biological Studies; University of South AustraliaCompletedObesity | Type2 DiabetesAustralia
-
HighTide Biopharma Pty LtdCompleted
-
Bristol-Myers SquibbCompletedDyslipidemia | Diabetes Mellitus, Non-Insulin-DependentAustralia
-
The George InstituteNational Health and Medical Research Council, Australia; University of British... and other collaboratorsCompletedHyperglycemia | Critical IllnessAustralia
-
Eli Lilly and CompanyTerminatedDiabetes Mellitus, Type 2Russian Federation, Spain, Germany, Australia, Austria, Israel, Czech Republic
-
Resverlogix CorpNucleus Network Ltd; Baker Heart and Diabetes InstituteCompleted
-
AstraZenecaCompletedDiabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1Australia
-
Bayside HealthUnknownSympathetic Activity in Individuals With the Metabolic Syndrome: Benefits of Lifestyle InterventionsMetabolic Syndrome XAustralia
-
MetaCure LimitedUnknownType 2 DiabetesAustralia, Austria, Greece, Italy, Poland, Serbia
-
QL Biopharmaceutical Australia Pty LtdNovotech (Australia) Pty Limited; Beijing QL Biopharmaceutical Co.,LtdRecruiting
-
Menzies School of Health ResearchWithdrawn
-
Carmot Therapeutics, Inc.Carmot Australia First Pty LtdRecruiting
-
Medical University of ViennaCompleted
-
GlaxoSmithKlineTerminated